Zobrazeno 1 - 10
of 83
pro vyhledávání: '"L. Ruskin"'
Autor:
Philip D Greenberg, Valentin Voillet, Raphael Gottardo, Kristin G Anderson, Breanna M Bates, Madison G Burnett, Susan L Ruskin, Yapeng Su, Magdalia L Suarez Gutierrez
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/02aa15847e644c8caf9301b40b6a786b
Autor:
Philip D Greenberg, Kristin G Anderson, Shannon K Oda, Breanna M Bates, Madison G Burnett, Magdalia Rodgers Suarez, Susan L Ruskin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)
Background In the USA, more than 50% of patients with ovarian cancer die within 5 years of diagnosis, highlighting the need for therapeutic innovations. Mesothelin (MSLN) is a candidate immunotherapy target; it is overexpressed by ovarian tumors and
Externí odkaz:
https://doaj.org/article/16c482feb17b4df89dbc5b52b72fb431
Publikováno v:
Системи управління, навігації та зв’язку. Збірник наукових праць. 2:90-94
Предметом вивчення статті є декомпозиційна обчислювальна процедура, яка використовує метод фазового укрупнення станів системи. Мета
Autor:
Philip D. Greenberg, Shannon K. Oda, Breanna M. Bates, Susan L. Ruskin, Kristin G. Anderson, Madison G. Burnett, Magdalia Rodgers Suarez
BackgroundIn the U.S., more than 50% of ovarian cancer patients die within 5 years of diagnosis, highlighting the need for innovations such as engineered T cell therapies. Mesothelin (Msln) is an attractive immunotherapy target for this cancer, as it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::794c480b791954a026fe52e6f7d6fbda
https://doi.org/10.1101/2021.07.30.454539
https://doi.org/10.1101/2021.07.30.454539
Autor:
Kristin G. Anderson, Yapeng Su, Madison G. Burnett, Breanna M. Bates, Magdalia L. Rodgers Suarez, Susan L. Ruskin, Aesha Vakil, Valentin Voillet, Raphael Gottardo, Philip Greenberg
Publikováno v:
Cancer Research. 82:3608-3608
Background: Less than half of ovarian cancer patients survive five years after diagnosis. This rate has changed little in the last 30 years, highlighting the need for novel therapies. A promising new strategy with the potential to control tumor growt
Autor:
Kristin G Anderson, Shannon K Oda, Breanna M Bates, Madison G Burnett, Magdalia Rodgers Suarez, Susan L Ruskin, Philip D Greenberg
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e003959
BackgroundIn the USA, more than 50% of patients with ovarian cancer die within 5 years of diagnosis, highlighting the need for therapeutic innovations. Mesothelin (MSLN) is a candidate immunotherapy target; it is overexpressed by ovarian tumors and c
Autor:
Magdalia Rodgers Suarez, Raphael Gottardo, Valentin Voillet, Philip D. Greenberg, Kristin E. Anderson, Yapeng Su, Aesha Vakil, Madison G. Burnett, Susan L. Ruskin, Breanna M. Bates
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A590-A590
BackgroundOver 20,000 women are diagnosed with ovarian cancer annually, and more than half will die within 5 years. This rate has changed little in the last 20 years, highlighting the need for therapy innovation. A promising new strategy with the pot
Autor:
Simon L. Ruskin
Publikováno v:
The American journal of digestive diseases. 13
1. The system of amino acids and coenzymes of the B Complex is necessary for the formation of the respiratory enzymes on which we depend for energy and growth.
Autor:
S L, RUSKIN
Publikováno v:
The American journal of digestive diseases. 13
Autor:
S L, RUSKIN
Publikováno v:
The Annals of otology, rhinology, and laryngology. 55(4)